Enhanced endothelium-dependent vasodilation in Fabry disease

被引:106
作者
Altarescu, G
Moore, DF
Pursley, R
Campia, U
Goldstein, S
Bryant, M
Panza, JA
Schiffmann, R
机构
[1] NINDS, Dev & Metab Neurol Branch, NIH, Bethesda, MD 20892 USA
[2] NHLBI, Cardiol Branch, NIH, Bethesda, MD USA
[3] NIH, Ctr Informat Technol, Bethesda, MD 20892 USA
[4] NIH, Off Res Serv, Bethesda, MD 20892 USA
关键词
acetylcholine; blood flow; endothelium-derived relaxing factors; lipids; nitric oxide; vasodilation;
D O I
10.1161/01.STR.32.7.1559
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-Fabry disease is an X-linked lysosomal storage disease secondary to deficiency of alpha -galactosidase A with resulting glycolipid accumulation, particularly globotriaosylceramide in arterial smooth muscle and endothelial cells. A systemic vasculopathy, including early-onset stroke, is prevalent without a clear pathogenesis. Methods-Seventeen normotensive and normocholesterolemic hemizygous Fabry patients (aged 21 to 49 years) and 13 control subjects (aged 21 to 48 years) were investigated by venous plethysmography, allowing assessment of forearm blood flow, Plethysmographic measurements were obtained at baseline and during intra-arterial infusion of acetylcholine and sodium nitroprusside both with and without NG-monomethyl L-arginine (L-NMMA). Results-Forearm blood flow was significantly higher in patients than in control subjects at all 3 acetylcholine doses (P=0.014). Patients had a greater response to acetylcholine even after the addition of L-NMMA (P=0.036). Conclusions-These results demonstrate an increased endothelium-mediated vascular reactivity in Fabry disease. The increased vessel response to acetylcholine with and without L-NMMA suggests altered functionality of non-NO endothelium-dependent vasodilatory pathways.
引用
收藏
页码:1559 / 1562
页数:4
相关论文
共 21 条
  • [1] ENZYMATIC DEFECT IN FABRYS DISEASE - CERAMIDETRIHEXOSIDASE DEFICIENCY
    BRADY, RO
    GAL, AE
    BRADLEY, RM
    MARTENSS.E
    WARSHAW, AL
    LASTER, L
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1967, 276 (21) : 1163 - &
  • [2] DeGraba T, 2000, ANN NEUROL, V47, P229, DOI 10.1002/1531-8249(200002)47:2<229::AID-ANA13>3.0.CO
  • [3] 2-T
  • [4] Desnick R.J., 1995, The Metabolic and Molecular Bases of Inherited Disease, P2741
  • [5] DESNICK RJ, 1997, MOL GENETIC BASIS NE, P443
  • [6] Félétou M, 1999, J PHYSIOL PHARMACOL, V50, P525
  • [7] THE OBLIGATORY ROLE OF ENDOTHELIAL-CELLS IN THE RELAXATION OF ARTERIAL SMOOTH-MUSCLE BY ACETYLCHOLINE
    FURCHGOTT, RF
    ZAWADZKI, JV
    [J]. NATURE, 1980, 288 (5789) : 373 - 376
  • [8] In eNOS knockout mice skeletal muscle arteriolar dilation to acetylcholine is mediated by EDHF
    Huang, A
    Sun, D
    Smith, CJ
    Connetta, JA
    Shesely, EG
    Koller, A
    Kaley, G
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2000, 278 (03): : H762 - H768
  • [9] ENDOTHELIUM-DERIVED RELAXING FACTOR PRODUCED AND RELEASED FROM ARTERY AND VEIN IS NITRIC-OXIDE
    IGNARRO, LJ
    BUGA, GM
    WOOD, KS
    BYRNS, RE
    CHAUDHURI, G
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (24) : 9265 - 9269
  • [10] Cerebrovascular complications of Fabry's disease
    Mitsias, P
    Levine, SR
    [J]. ANNALS OF NEUROLOGY, 1996, 40 (01) : 8 - 17